Financial Analysis of the Access to Pharmacotherapy for Rare Diseases in Bulgaria

Modern Economy

ISSN Print: 2152-7245
ISSN Online: 2152-7261
www.scirp.net/journal/me
E-mail: [email protected]

Citations

"Financial Analysis of the Access to Pharmacotherapy for Rare Diseases in Bulgaria"
written by Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Georgi Momekov, Guenka Petrova,
published by Modern Economy, Vol.5 No.5, 2014

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	СЪЩНоСт И ИзПоЛзвАНЕ НА ИкоНоМИЧЕСкИ АНАЛИзИ ПРИ ПРовЕЖДАНЕ НА НАУЧНоИзСЛЕДовАтЕЛСкА РАзРАботкА
	Тзуни, 2020

[2]	Orphan medicinal products' access to the Bulgarian pharmaceutical market–challenges and obstacles
	Ecosystem Health and Sustainability, 2018

[3]	Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines—Part II
	Modern Economy, 2014

[4]	Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines-Part II
	Modern Economy, 2014

	[email protected]
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Top

Modern Economy

Modern Economy

Journals Menu

Guidelines & Policies

Home

About SCIRP

Service

Policies

[1]	Orphan medicinal products’ access to the Bulgarian pharmaceutical market – challenges and obstacles Expert Opinion on Orphan Drugs, 2017 DOI:10.1080/21678707.2018.1421063

[2]	Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines—Part II Modern Economy, 2014 DOI:10.4236/me.2014.55047